Preparing for Gene Therapy

This tool is currently , and is associated with the following interest areas: Industry, Sites

As gene therapy trials for DMD progress in the US, the DMD Hub is committed to preparing UK sites for its arrival and eventual delivery.  

Read more below:


Access Level
Gene Therapy Patient Referral Pathways White Paper
Access Level
Identifying and preparing for the challenges ahead
Access Level
Lessons learnt from existing gene therapy trials
Access Level
Update on current Gene Therapy trials
Access Level
Good Clinical Practice for Advanced Therapy Medicinal Products (ATMPs)
Access Level
Pharmacy
Access Level
Advice to Patients after AAV-gene therapy
Access Level
Considerations for safe implementation
Access Level
Gene Therapy Educational Resources
Access Level
Enpr-EMA recommendations on trial preparedness

We have placed cookies on your computer to help make this website better. For more information please click here

By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here